The Hanbury Medal
Nominations for the 2025 Hanbury Medal open in Spring 2024.
For high excellence in the prosecution or promotion of original research in the Natural History and Chemistry of Drugs.
Awarded in memory of British botanist and pharmacologist Daniel Hanbury, who died in 1875.
Who is eligible?
Nominees for the Hanbury Medal must be:
- Distinguished pharmacy professionals with a long career involving pharmaceutical research
- Significant contributors to pharmaceutical science
- A recognised authority within pharmacy
- Have had a substantial, positive, and lasting impact on the field
- Actively encouraging juniors to further their knowledge
- An RPS member.
How to nominate
Nominations for the 2025 Hanbury Medal open in Spring 2024.
To be considered, nominations must include:
- A CV on behalf of the nominee
- A biography detailing their career to date and notable activities within the field of pharmaceutical sciences2
- A letter of justification expressing why you believe they should be considered for the award
You cannot nominate yourself for the Hanbury Medal.
The winner will be announced in Spring 2025.1
To ensure an inclusive and wide field of candidates is reached we will be reaching out to known stakeholders, including the Academy of Pharmaceutical Sciences, Joint Pharmaceutical Analysis Group and Industrial Pharmacy Forum.
Find out more about the Hanbury Medal.
Any questions about eligibility or nominations? Contact the RPS Science & Research team
1 A dedicated panel created by the RPS’ Science & Research Team and the RPS Science and Research Committee will review the nominations for the medal and select a medal winner. The proposed name is submitted for ratification to the RPS Executive Team, National Pharmacy Board Chairs, and the President.
2 The RPS’ definition of a Pharmaceutical Scientist is “an individual working in the basic, applied or the social sciences impinging on the discovery, development, delivery, quality, safety, efficacy, regulation or usage of medicines and medical devices and their educational development in all its many aspects and for the ultimate benefit of the patient and public.”